NUCRYST PHARMACEUTICALS
NUCRYST Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation using SILCRYST(TM), its patented atomically disordered nanocrystalline silver technology. NUCRYST licensed world-wide rights for SILCRYST(TM) wound care coating products to Smith & Nephew plc, which markets these products in over 30 countries under their Acticoat(TM) trademark. NUCRYST has developed its proprietary nanocrystalline silver in a powder form, referred to as NPI 32101, for use in medical devices and as an active pharmaceutical ingredient.
NUCRYST PHARMACEUTICALS
Industry:
Manufacturing Medical Pharmaceutical
Founded:
1997-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.nucryst.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics WordPress Wordpress Plugins WordPress 6.0 Gravatar Profiles Google Analytics Classic
Stock Details
Official Site Inspections
http://www.nucryst.com
- Host name: 199.59.243.227
- IP address: 199.59.243.227
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NUCRYST Pharmaceuticals"
NUCRYST Pharmaceuticals - Crunchbase Company Profile & Funding
NUCRYST Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation using SILCRYST (TM), its patented atomically disordered …See details»
NUCRYST Pharmaceuticals Company Profile | Management and
NUCRYST Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation based on its nanocrystalline silver technology. Our …See details»
NUCRYST Pharmaceuticals - Overview, News & Similar companies
Feb 21, 2018 · View NUCRYST Pharmaceuticals (www.nucryst.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well …See details»
NUCRYST Pharmaceuticals Corp - Company Profile and News
NUCRYST Pharmaceuticals Corp. provides pharmaceuticals services. The Company develops and manufactures medical products that fight infection and inflammation.See details»
NUCRYST Pharmaceuticals - Products, Competitors, Financials, …
NUCRYST Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation using its patented atomically disordered nanocrystalline silver …See details»
NUCRYST Pharmaceuticals (Acticoat Operations) - PitchBook
Information on acquisition, funding, investors, and executives for NUCRYST Pharmaceuticals (Acticoat Operations). Use the PitchBook Platform to explore the full profile.See details»
NUCRYST Announces Agreement to Sell Acticoat Business and
Nov 11, 2009 · NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS) develops, manufactures and commercializes medical products that fight infection and inflammation using …See details»
NUCRYST Pharmaceuticals - Crunchbase
NUCRYST Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation usingSee details»
Smith & Nephew Inc. Completes Acquisition of the Assets of …
Dec 23, 2009 · SASKATCHEWAN, Canada, Dec. 22 /PRNewswire-FirstCall/ -- The Advanced Wound Management division of Smith & Nephew plc, announced today that its affiliates have …See details»
NUCRYST Pharmaceuticals - Updates, News, Events, Signals
Nov 10, 2009 · NUCRYST Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation usingSee details»
NUCRYST Pharmaceuticals - PitchBook
Information on acquisition, funding, investors, and executives for NUCRYST Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Smith & Nephew (SNN) to Acquire NUCRYST Pharma. (NCST) …
Nov 11, 2009 · NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST) announced today the execution of a definitive agreement with subsidiaries of Smith & Nephew plc.See details»
Westaim Announces Amalgamation Agreement with NUCRYST
Nov 11, 2009 · NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS) develops, manufactures and commercializes medical products that fight infection and inflammation using …See details»
NUCRYST Pharmaceuticals Inc. Nanomaterials - Nano Orbit
NUCRYST Pharmaceuticals Corp.'s start came from the desire to improve and broaden silver's therapeutic properties. Using their understanding of quantum mechanics, NUCRYST scientists …See details»
Westaim Announces Amalgamation Agreement With NUCRYST …
Nov 11, 2009 · NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS) develops, manufactures and commercializes medical products that fight infection and inflammation using …See details»
NUCRYST Pharmaceuticals granted new patent for treatment of acne
Jan 10, 2014 · NUCRYST Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation using its patented atomically disordered …See details»
NUCRYST Announces Completion of Amalgamation - Newswire
PRINCETON, NJ , Feb. 8 /CNW/ - NUCRYST Pharmaceuticals Corp. ("Nucryst") (TSX: NCS / NASDAQ:NCST) today is pleased to announce the completion of the previously announced …See details»
NUCRYST Pharmaceuticals Corp. Announces Pricing For Initial
Dec 22, 2005 · NUCRYST Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation based on its nanocrystalline silver technology.See details»
Nanosilver in medicine - RSC Education
Nanocrystalline silver is a patented technology of NUCRYST Pharmaceutical Corp. and SILCRYSTTM is a trade mark used under licence by Smith & Nephew. Acticoat is a trade …See details»
News in Brief NUCRYST Pharmaceuticals granted new patent for …
NUCRYST Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation using its patented atomically dis- ordered nanocrystalline silver …See details»